IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, D. A.
Right arrow Articles by Kitada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, D. A.
Right arrow Articles by Kitada, S.

Investigative Ophthalmology & Visual Science, Vol 31, 2136-2144, Copyright © 1990 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation

DA Lee, TC Lee, AE Cortes and S Kitada
Jules Stein Eye Institute, UCLA School of Medicine 90024-7004.

Scar formation and fibrosis are the most common causes of ultimate glaucoma filtration surgery failure. The authors used Coulter counter, hexosaminidase, and 3H-thymidine assays to evaluate the effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast growth in tissue culture. Fifty percent inhibitory doses (ID50) for each drug on different days of incubation with fibroblasts were calculated with these three assays. Among these four drugs only daunorubicin exerted a significant effect on cellular attachment, showing cytotoxicity at 4 x 10(-6) M. However, all drugs had antiproliferative effects. Daunorubicin was the most potent drug in the concentration range studied. Mithramycin had a narrow therapeutic range in tissue culture. Cellular antiproliferative responses to mitomycin and bleomycin were more gradual. These drugs have potential applications in the prevention of glaucoma filtration surgery failure.


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
B. A. Francis, L. T. Du, K. Najafi, R. Murthy, U. Kurumety, N. Rao, and D. S. Minckler
Histopathologic Features of Conjunctival Filtering Blebs
Arch Ophthalmol, February 1, 2005; 123(2): 166 - 170.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Mietz, J. M. Esser, G. Welsandt, N. Kociok, A. Hueber, A. Joussen, P. Esser, and G. K. Krieglstein
Latanoprost Stimulates Secretion of Matrix Metalloproteinases in Tenon Fibroblasts Both In Vitro and In Vivo
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5182 - 5188.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
R. Rahbar, D. T. Jones, R. C. Nuss, D. W. Roberson, M. A. Kenna, T. J. McGill, and G. B. Healy
The Role of Mitomycin in the Prevention and Treatment of Scar Formation in the Pediatric Aerodigestive Tract: Friend or Foe?
Arch Otolaryngol Head Neck Surg, April 1, 2002; 128(4): 401 - 406.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
M. Diestelhorst and S. Grisanti
Photodynamic Therapy to Control Fibrosis in Human Glaucomatous Eyes After Trabeculectomy: A Clinical Pilot Study
Arch Ophthalmol, February 1, 2002; 120(2): 130 - 134.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
E G Kemp, A N Harnett, and S Chatterjee
Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias
Br. J. Ophthalmol., January 1, 2002; 86(1): 31 - 34.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S. L Liao, S. C S Kao, J. H S Tseng, M. S Chen, and P. K Hou
Results of intraoperative mitomycin C application in dacryocystorhinostomy
Br. J. Ophthalmol., August 1, 2000; 84(8): 903 - 906.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
H. Demirci, S. A. McCormick, and P. T. Finger
Topical Mitomycin Chemotherapy for Conjunctival Malignant Melanoma and Primary Acquired Melanosis With Atypia: Clinical Experience With Histopathologic Observations
Arch Ophthalmol, July 1, 2000; 118(7): 885 - 891.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S. Grisanti, M. Diestelhorst, K. Heimann, and G. Krieglstein
Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery
Br. J. Ophthalmol., December 1, 1999; 83(12): 1353 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
P. T Finger, G. Czechonska, and S. Liarikos
Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia
Br. J. Ophthalmol., May 1, 1998; 82(5): 476 - 479.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Association for Research in Vision and Ophthalmology